Persistence of viable tumor cells after radiation and chemotherapy for stage IIIB non-small cell lung cancer: An early marker of treatment failure [6]

Journal of Thoracic and Cardiovascular Surgery

Volumn 121, Issue 2, 2001, Pages 403-

  Andre, F ^a   Grunewald, D ^a   Le Chevalier, T ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; LOMUSTINE; VINDESINE;

CANCER CONTROL; CANCER STAGING; CANCER SURVIVAL; CELL VIABILITY; HUMAN; LETTER; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; SALVAGE THERAPY; TREATMENT FAILURE; TUMOR CELL;

EID: 0035136637     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1067/mtc.2001.111203     Document Type: Letter

References (5)

1. Improved survival in stage III non-small cell lung cancer: Seven year follow-up of the CALGB8433 trial
2. ASTRO plenary: Effect of chemotherapy on locally advanced non-small cell lung carcinoma: A randomized study of 353 patients
3. Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stage IIIA (N2) and stage IIIB non small cell lung cancer: Mature results of a SWOG phase II study 8805
4. Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hyperfractionated accelerated radiotherapy and definitive surgery in locally advanced non-small lung cancer: Mature results of a phase II study
5. Impact of preoperative bimodality induction including twice-daily radiation therapy on tumor regression and survival in stage III non small cell lung cancer